Second Patent Granted – U.S. Patent 8,693,628

On April 8th 2014, the U.S. Patent and Trademark Office granted IKOMED Technologies Inc. a second patent regarding the core technology behind the company’s innovative fluoroscopy radiation-reduction system. The U.S. Patent No. 8,693,628, “X-ray System”, is part of a family of patent applications filed by IKOMED describing the use of its proprietary actuator technology and image processing to reduce medical radiation to patients, doctors and medical staff.

Read More

Second Round of Financing Completed

Following successful demonstration of IKOMED’s patented X-ray radiation-reduction technology with commercial fluoroscopy imaging equipment, IKOMED Technologies Inc. has finalized its second round of financing with several million dollars of new investment. Led by a group of Canadian private investors, this round will enable IKOMED to expand its product offering and build manufacturing capability for its X-ray radiation reduction system. Following this financing, Mr. Amos Michelson will be joining IKOMED’s board of directors. Mr. Michelson commented, “I see IKOMED’s product offering as of great value and trust its technology will be adopted by fluoroscopy-imaging leaders as part of their commitment to keeping X-ray exposure rates as low as reasonably achievable”

Read More

First Patent Granted – U.S. Patent 7,983,391

On July 19th 2011, the U.S. Patent and Trademark Office granted IKOMED Technologies Inc. a patent that depicts part of the core technology behind the company’s innovative fluoroscopy radiation-reduction system. The U.S. Patent No. 7,983,391, “System for reduction of exposure to X-ray radiation”, is the first in a family of patent applications filed by IKOMED. This patent and the patents pending approval establish IKOMED’s strong Intellectual Property position and affirm the uniqueness of IKOMED’s technology. This patent is a key step toward making this revolutionary technology the gold standard in fluoroscopy radiation reduction, improving the long-term health of patients and medical staff.

Read More

First Round of Financing Completed

Led by Vancouver-based private investors and Advanced Applied Physics Solutions, IKOMED Technologies Inc. has finalized its first round of financing. This round will enable IKOMED to develop and test its technology for fluoroscopy radiation reduction. Each year, millions of patients and medical staff risk radiation exposure from the fluoroscopy imaging equipment used to guide surgeons through minimally invasive surgeries. IKOMED’s innovative technology will offer up to ten-fold reduction in radiation exposure. Improving the long-term health of patients and medical staff, this reduction of ionizing radiation exposure will also enable the development of longer and more complex minimally invasive surgical procedures.

Read More